Anti-RBM11 antibody (ab127553)
- Datasheet
- References
- Protocols
Overview
-
Product name
Anti-RBM11 antibody
See all RBM11 primary antibodies -
Description
Rabbit polyclonal to RBM11 -
Host species
Rabbit -
Tested applications
Suitable for: WBmore details -
Species reactivity
Reacts with: Human -
Immunogen
Recombinant protein fragment corresponding to a region within amino acids 1-144 of Human RBM11 (UniProt P57052).
-
Positive control
- NT2D1 and IMR32 whole cell lysates; U-87 MG cell lysate
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles. -
Storage buffer
pH: 7.00
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 1.21% Tris, 0.75% Glycine, 20% Glycerol -
Concentration information loading... -
Purity
Immunogen affinity purified -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Associated products
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
Applications
Our Abpromise guarantee covers the use of ab127553 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| WB | 1/500 - 1/3000. Predicted molecular weight: 32 kDa. |
Target
-
Relevance
RBM11, also known as RNA binding motif protein 11, is a human gene. 2 isoforms of the human protein are produced by alternative splicing. -
Database links
- Entrez Gene: 54033 Human
- SwissProt: P57052 Human
- Unigene: 283828 Human
-
Alternative names
- Putative RNA binding protein 11 antibody
- RNA binding motif protein 11 antibody
- Splicing regulator RBM11 antibody
Images
-
Western blot - Anti-RBM11 antibody (ab127553)All lanes : Anti-RBM11 antibody (ab127553) at 1/1000 dilution
Lane 1 : NT2D1 whole cell lysate
Lane 2 : IMR32 whole cell lysate
Lysates/proteins at 30 µg per lane.
Predicted band size: 32 kDa
12% SDS PAGE
Protocols
References
ab127553 has not yet been referenced specifically in any publications.
